• SENSEX 74,781.76
    -120.83 (--0.16%)
  • BANKNIFTY 56,471.95
    176.40 (+0.31%)
  • Molbio Diagnosti
    1,393.10 925.80(%)
  • Pine Labs
    206.10 283.70(%)
  • Larsen & Toubro
    3,880.55 3,288.65(%)
  • HDFC Bank
    708.90 1,020.35(%)
  • Power Grid Corpn
    268.30 250.05(%)
  • ESDS Software
    1,716.35 1,560.35(%)
  • Trent
    2,815.00 3,507.32(%)
  • Raymond
    1,024.00 869.05(%)
  • Metro Brands
    924.20 883.40(%)
  • Reliance Industries
    1,253.20 1,250.55(%)
  • Billionbrains
    200.90 227.00(%)
  • Ather Energy
    1,615.00 521.75(%)
  • One 97
    1,829.50 1,759.05(%)
  • Hind.Aeronautics
    4,861.65 3,479.20(%)
  • UPL
    567.25 558.00(%)
  • HDFC Life Insur.
    531.15 796.60(%)
  • Bajaj Finance
    1,015.40 788.40(%)
  • Lodha Developers
    1,076.00 650.85(%)
  • Dhoot Transmission
    1,727.35 1,673.50(%)
  • Britannia Inds.
    4,946.05 5,000.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Acutaas Chemicals Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 73056.0
  • ISIN : INE00FF01025
3,451.40 210 (6.47%)
  • As on 11 Sep 2026 (EOD)

  • Today’s Low

    3,220.00

  • Today’s High

    3,464.00

  • Open

    3,241.80

  • Perv Close

    3,241.80

  • 52W Low

    1,302.00

  • 52W High

    3,740.00

Key Indicators

  • P/E(TTM)

    71.10

  • Mar.Cap (₹Cr.)

    28,257.00

  • Div & Yield %

    0.07

  • Book Value(₹)

    203.78

  • Debt-Equity Ratio

    6.47

  • AGM Date

    10-Sep-2026

  • EPS

    48.54

  • P/E Ratio

    71.10

Financials Ratios

  • Debt-Equity Ratio

    0.17

  • Mar.Cap (₹Cr.)

    28,257.00

  • RONW (%)

    10.67

  • ROCE (%)

    16.07

Score Board

  • Equity (₹ in Cr.)

    40.94

  • BV (₹)

    203.80

  • Sales( ₹ in Cr.)

    1,323.79

  • NP (in Cr.)

    363.91

  • NP Var(%)

    132.0

  • Div%

    50.0

  • CPS (₹)

    48.50

  • EPS (₹)

    44.40

  • Traded Value (₹ in Lakhs)

    28,255.77

  • 52 Week High

    3,740.00

  • 52 Week Low

    1,302.00

  • Price BSE

    3451.0

  • Price NSE

    3,451.00

  • Market Capital( in Cr.)

    28,255.77

  • P/C Ratio

    71.20

  • P/E Ratio

    77.60

  • Price Vs.BV

    44.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,323.79 989.83 687.58 616.73 520.14 340.61
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,323.79 989.83 687.58 616.73 520.14 340.61
Other Income 45.88 18.34 13.79 4.32 2.76 1.33
Stock Adjustments 30.69 18.65 26.94 14.96 9.50 -4.81
Total Income 1,400.36 1,026.82 728.31 636.01 532.40 337.13
EXPENDITURE :            
Raw Materials 592.50 566.84 434.96 345.85 282.33 174.87
Power and Fuel Cost 37.15 29.99 25.69 22.28 21.40 5.26
Employee Cost 111.35 80.95 60.92 48.84 41.37 20.99
Other Manufacturing Expenses 66.04 51.23 47.46 46.71 49.53 40.65
Selling and Administration Expenses 55.65 45.84 32.33 36.56 27.22 11.47
Miscellaneous Expenses 8.78 8.49 37.26 8.78 2.61 2.35
Employee Benefit Expenses 111.35 80.95 60.92 48.84 41.37 20.99
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 871.48 783.34 638.61 509.03 424.45 255.59
Operating Profit 528.89 243.48 89.69 126.98 107.94 81.53
Interest 3.08 5.86 5.89 2.41 6.41 5.62
Gross Profit 525.81 237.62 83.80 124.57 101.53 75.91
Depreciation 33.03 24.05 14.69 12.34 10.08 4.19
Profit Before Tax 492.78 213.57 69.11 112.23 91.45 71.72
Current Tax 115.49 46.97 20.91 26.38 16.72 17.56
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 11.11 7.06 4.51 2.50 2.78 0.16
Reported Net Profit 366.17 159.55 43.68 83.34 71.95 54.00
Extraordinary Items 2.26 2.61 -15.35 -0.55 -0.10 -0.61
Adjusted Net Profit 363.91 156.94 59.03 83.89 72.05 54.61
Adjustment below Net Profit -0.29 -0.11 -0.09 0.17 0.00 -21.03
P & L Balance brought forward 455.40 308.24 275.58 203.00 131.28 97.48
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 12.28 12.28 10.93 10.93 0.00 0.00
P & L Balance carried down 809.01 455.40 308.24 275.58 203.23 130.45
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 50.00 30.00 30.00 30.00 30.00 0.00
Dividend Per Share(Rs) 2.50 1.50 3.00 3.00 3.00 0.00
Earnings Per Share-Unit Curr 44.73 19.49 11.84 22.87 19.75 17.14
Earnings Per Share(Adj)-Unit Curr 44.73 9.75 5.92 11.44 9.88 -
Book Value 203.78 160.21 183.05 161.04 142.16 52.05
Book Value(Adj)-Unit Curr 203.78 80.11 91.53 80.52 71.08 -

Shareholding Pattern

  • Promoter Group

    32.66%

  • Public Share Holding

    67.34%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 26,741,416 32.66 26,741,416 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 26,741,416 32.66 26,741,416 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 8,473 0.01 8,473 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,570 0.00 1,570 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 17,690,137 21.61 17,690,137 244
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,957,611 3.61 2,957,611 14
Mutual Funds / UTI 11,598,952 14.17 11,598,952 32
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,453,086 1.77 1,453,086 39
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 33,709,829 41.17 33,709,829 331
2] Non Institution
Bodies Corporate 1,026,375 1.25 1,026,375 821
Clearing Members 163,989 0.20 163,989 29
Directors of their Relatives 623,200 0.76 623,200 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,071,708 1.31 1,071,708 4,079
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 481,820 0.59 481,820 2,522
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,777,426 8.28 6,777,426 19
Individuals holding nominal share capital up to Rs. 1 lakh 11,004,545 13.44 11,004,545 117,586
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 75,338 0.09 75,338 11
Others 2,500 0.00 2,500 2
Sub Total 21,419,877 26.16 21,419,877 125,235
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 81,871,122 100.00 81,871,122 125,569

Company Background

Acutaas Chemicals LtdPharmaceuticals - Indian - Bulk Drugs

  • Acutaas Chemicals Ltd
  • BSE Code : 73056.0
  • ISIN : INE00FF01025

  • Incorporation Year

    2007

  • Registered Office

    Plot No 440/4 5&6
    Road No 82/A GIDC Sachin, Surat,
    Gujarat-394230

  • Telephone

    91-261-2397193/91-7227977744

  • FAX

    91-261-2398436

  • Chairman

    Nareshbhai Ramjibhai Patel

  • Managing Director

  • Company Secretary

  • Auditor

    Maheshwari & Co

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Acutaas Chemicals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Acutaas Chemical 3,451.25 1,369.67 1,323.79 71.10 32.74
Abbott India 25,272.60 7,217.19 6,929.05 33.26 43.78
Astrazeneca Phar 6,858.65 2,304.07 2,275.58 101.09 27.86
Glaxosmi. Pharma 2,840.80 3,932.76 3,790.20 45.38 58.17
Novartis India 2,425.05 393.10 354.33 61.24 15.94
Cipla 1,380.00 20,102.60 18,979.95 36.27 13.88
Bliss GVS Pharma 703.70 773.53 729.81 65.40 12.51
Amrutanjan Healt 493.80 520.13 502.55 26.45 24.16
Fermenta Biotec. 483.30 474.15 450.25 22.56 18.77
Guj. Themis Bio. 430.80 168.25 165.82 115.19 18.05
Ambalal Sarabhai 41.45 19.52 3.94 76.76 6.77